These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 15387095)

  • 1. The impact of PELD on OPTN liver allocation: preliminary results.
    Davies DB
    Clin Transpl; 2003; ():13-20. PubMed ID: 15387095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of MELD on OPTN liver allocation: preliminary results.
    Edwards EB; Harper AM
    Clin Transpl; 2002; ():21-8. PubMed ID: 12971434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. National and regional analysis of exceptions to the Pediatric End-Stage Liver Disease scoring system (2003-2004).
    Shneider BL; Suchy FJ; Emre S
    Liver Transpl; 2006 Jan; 12(1):40-5. PubMed ID: 16382460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pediatric end-stage liver disease (PELD) model as a predictor of survival benefit and posttransplant survival in pediatric liver transplant recipients.
    Barshes NR; Lee TC; Udell IW; O'mahoney CA; Karpen SJ; Carter BA; Goss JA
    Liver Transpl; 2006 Mar; 12(3):475-80. PubMed ID: 16498644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of a continuous disease severity score to the OPTN liver waiting list.
    Edwards EB; Harper AM
    Clin Transpl; 2001; ():19-24. PubMed ID: 12211782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection of pediatric candidates under the PELD system.
    McDiarmid SV; Merion RM; Dykstra DM; Harper AM
    Liver Transpl; 2004 Oct; 10(10 Suppl 2):S23-30. PubMed ID: 15384170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Model for end-stage liver disease: impact of the new deceased donor liver allocation policy in São Paulo, Brazil.
    Monteiro F; Coria SA; Boni R; Pereira LA
    Transplant Proc; 2009; 41(1):226-8. PubMed ID: 19249520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of the first year of the new liver allocation plan.
    Freeman RB; Wiesner RH; Edwards E; Harper A; Merion R; Wolfe R;
    Liver Transpl; 2004 Jan; 10(1):7-15. PubMed ID: 14755772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of the MELD score and the UNOS adult liver allocation system.
    Martin AP; Bartels M; Hauss J; Fangmann J
    Transplant Proc; 2007 Dec; 39(10):3169-74. PubMed ID: 18089345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regionwide sharing for status 1 liver patients--beneficial impact on waiting time and pre- and posttransplant survival.
    Humar A; Khwaja K; Glessing B; Larson E; Asolati M; Durand B; Lake J; Payne WD
    Liver Transpl; 2004 May; 10(5):661-5. PubMed ID: 15108258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organ allocation for liver-intestine candidates.
    Horslen S
    Liver Transpl; 2004 Oct; 10(10 Suppl 2):S86-9. PubMed ID: 15382223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New national liver transplant allocation policy: is the regional review board process fair?
    Voigt MD; Zimmerman B; Katz DA; Rayhill SC
    Liver Transpl; 2004 May; 10(5):666-74. PubMed ID: 15108259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is the model of end-stage liver disease (MELD) valid in Israel? A critical analysis of liver transplant waiting list mortality.
    Ben-Haim M; Carmiel M; Katz P; Shabtai E; Oren R; Nakache R
    Isr Med Assoc J; 2006 Sep; 8(9):605-9. PubMed ID: 17058408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the 2006 U.S. thoracic organ allocation change: analysis of local impact on organ procurement and heart transplantation.
    Nativi JN; Kfoury AG; Myrick C; Peters M; Renlund D; Gilbert EM; Bader F; Singhal AK; Everitt M; Fisher P; Bull DA; Selzman C; Stehlik J
    J Heart Lung Transplant; 2010 Mar; 29(3):235-9. PubMed ID: 19782588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for liver transplantation waiting list mortality.
    Fink MA; Berry SR; Gow PJ; Angus PW; Wang BZ; Muralidharan V; Christophi C; Jones RM
    J Gastroenterol Hepatol; 2007 Jan; 22(1):119-24. PubMed ID: 17201891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Child-Turcotte-Pugh and pediatric end-stage liver disease scoring systems to predict morbidity and mortality of children awaiting liver transplantation.
    Dehghani SM; Gholami S; Bahador A; Haghighat M; Imanieh MH; Nikeghbalian S; Salahi H; Davari HR; Mehrabani D; Malek-Hosseini SA
    Transplant Proc; 2007 Dec; 39(10):3175-7. PubMed ID: 18089346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of broader regional sharing of livers: 2-year results of "Share 35".
    Edwards EB; Harper AM; Hirose R; Mulligan DC
    Liver Transpl; 2016 Apr; 22(4):399-409. PubMed ID: 26890858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying the futile pediatric liver re-transplant in the PELD era.
    Lao OB; Dick AA; Healey PJ; Perkins JD; Reyes JD
    Pediatr Transplant; 2010 Dec; 14(8):1019-29. PubMed ID: 21108708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status of thoracic organ transplantation and allocation in the United States.
    Coke M; Edwards LB
    Clin Transpl; 2004; ():17-26. PubMed ID: 16704135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient selection criteria for liver transplantation.
    Yu AS; Keeffe EB
    Minerva Chir; 2003 Oct; 58(5):635-48. PubMed ID: 14603144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.